Latest Articles
-
Why Is Intuitive Surgical Stock Up 80%?
Intuitive Surgical (NASDAQ: ISRG) has seen solid gains of over 80% from levels of around $270 in early January 2021 to nearly $500 now, vs. an increase of about 50% for the S&P 500 over this period. This can primarily be attributed to a 74%...
-
What’s Happening With American Airlines Stock?
American Airlines stock (NASDAQ: AAL) currently trades at $11 per share, nearly 60% below its highs of $26 seen in June 2021. In comparison, its peer – United Airlines stock (NASDAQ:UAL) – is down 22% over this period. Most of the U.S. airlin...
-
Li Auto Grows Despite China’s Economic Struggles. Can The Stock Recover?
Li Auto (NASDAQ:LI), the largest of the emerging EV players in China, delivered 48,122 vehicles for July 2024 – an increase of 38% percent year-over-year, although they were down by 5.6% versus July. Deliveries for the eight months from Jan...
-
Why First Solar Stock Gained 30% This Year
First Solar stock (NASDAQ:FSLR) has had a solid year, rising by about 30% year-to-date. In comparison, Enphase Energy stock (NASDAQ:ENPH), another solar component player, has seen its stock decline by 8% over the same period. First Solar stock ha...
-
Which Industrial Sector Heavyweight Looks Better: Deere or Caterpillar?
Given its better valuation, we believe Deere stock (NYSE: DE) is a better pick than its peer, Caterpillar stock (NYSE: CAT) for the next three years. CAT stock trades at 2.6x revenues, versus 1.8x for DE. We think this gap in their valuation ...
-
Time To Exchange Nasdaq Stock After Its 23% Gains This Year?
NASDAQ stock (NASDAQ: NDAQ) has gained 23% YTD as compared to a 17% rise in the S&P500 index. In sharp contrast, Nasdaq’s peer CME Group (NASDAQ: CME) is up 5% YTD. Overall, at the current price of $71 per share, it is trading at the s...
-
What’s Behind The 2x Jump In AbbVie Stock?
AbbVie stock (NYSE: ABBV) has more than doubled in value since early January 2021 – jumping from levels of $90 then to around $195 now – vs. an increase of about 50% for the S&P 500 over this period. This can primarily be attrib...
-
Dollar General’s 30% Stock Crash Makes These Alternatives Look Like Bargain Deals
If you are a Dollar General (NYSE:DG) investor reeling from the stock’s 30% plus drop on Thursday after it slashed its full-year revenue growth and profit forecasts, it might be time to look elsewhere. As of this moment, we find that Brookf...
-
Strong Q2 Showing Pushes Autodesk Stock Up 6%: What’s Next?
Autodesk stock (NASDAQ: ADSK) price rose by 5.9% on Thursday, 29th August, even as the benchmark S&P 500 index traded sideways. Autodesk’s peer Oracle (NYSE: ORCL) did not have a good day either, with its stock barely moving the needle...
-
How Did Chipotle Stock Gain 20% This Year Despite Inflationary Headwinds?
After a 20% increase since the beginning of this year, at the current price of around $56 per share, we believe Chipotle Mexican Grill stock (NYSE: CMG), a fast-casual restaurant chain that focuses on fresh and organic ingredients in burritos, ...
-
Why Abbott Stock Looks More Attractive Than Its Medical Devices Peer
Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT. Although Medtronic is slightly more profitable, Abbot...
-
Could Nvidia Stock Crash To $40?
Could Nvidia stock (NASDAQ:NVDA) fall to $40 in the next few years from the roughly $120 level it is at currently? Does this sound absolutely r idiculous? Consider this – about a year ago, NVDA stock was trading at around $50, almost 60% ...
-
Abercrombie Reports Strong Q2 Beat, Yet Its Stock Tanks 17%: What’s Going On?
Abercrombie & Fitch (NYSE: ANF), a specialty retailer selling casual clothing and footwear, fell around 17% on Wednesday, 28th August, as compared to a 0.6% decline in the S&P 500 index. In comparison, ANF’s peer American Eagle ...
-
What Helped Insulet Stock Gain 10% This Week?
Insulet stock (NASDAQ: PODD) currently trades around $200 per share, about 35% lower than the levels of over $300 seen in early November 2021. In comparison, its peer – DexCom stock (NASDAQ:DXCM) – is down 55% over this period. The two stocks t...
-
Johnson & Johnson Poised To Do Well, But Are These Steady Eddie Stocks Better Bets?
If you are a Johnson & Johnson (NYSE:JNJ) investor and have been enjoying the stock’s steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita (NYSE:DVA) – a healthcare company focused on kidney dialys...
